FDA OKs Sub-Q Vedolizumab for Crohn ' s Maintenance Therapy FDA OKs Sub-Q Vedolizumab for Crohn ' s Maintenance Therapy

Subcutaneous administration of vedolizumab is now approved for maintenance therapy in adults with moderate to severe active Crohn ' s disease after induction therapy with intravenous vedolizumab.Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news